Jay Pharma to File IND Applications to FDA for a clinical study of proprietary formulations in Radiodermatitis and a combination Therapy in Glioblastoma

Source :: Legal Monitor Worldwide. July 31, 2020
Publication Year :: 2020
Abstract: AMERI Holdings, Inc. (NASDAQ: AMRH) ('Ameri'), announced that its proposed amalgamation partner Jay Pharma Inc. ('Jay Pharma' or 'the Company') has announced the addition of new senior staff as the [...]

Subjects :: United States. Food and Drug Administration -- Technology application
Clinical trials -- Technology application
Drug approval -- Technology application
Glioblastomas -- Drug therapy
Technology application
Business, international
Law

Tools